Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
Mayo Clinic Hospital in Arizona, Phoenix, Arizona Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut Yale University, New Haven, Connecticut Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut Mayo Clinic in Florida, Jacksonville, Florida Moffitt Cancer Center, Tampa, Florida University of Kansas Cancer Center, Kansas City, Kansas University of Kansas Cancer Center-Overland Park, Overland Park, Kansas University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas Mayo Clinic in Rochester, Rochester, Minnesota Ohio State University Comprehensive Cancer Center, Columbus, Ohio University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma VCU Massey Comprehensive Cancer Center, Richmond, Virginia